
FTBMT, a novel and selective GPR52 agonist, demonstrates antipsychotic-like and procognitive effects in rodents revealing a potential therapeutic agent for schizophrenia
Nishiyama, Keiji, Suzuki, Hirobumi, Harasawa, Toshiya, Suzuki, Noriko, Kurimoto, Emi, Kawai, Takanori, Maruyama, Minoru, Komatsu, Hidetoshi, Sakuma, Kensuke, Shimizu, Yuji, Shimojo, MasatoLangue:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.117.242925
Date:
August, 2017
Fichier:
PDF, 2.60 MB
english, 2017